Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...

Pfizer only picked up an accelerated approval from the FDA for its Braftovi-based combination regimen for colorectal cancer ...

Rice University chemist and director of the university’s Synthesis X Center Han Xiao and cancer biologist Dihua Yu of The ...

A revolutionary personalized cancer vaccine developed by Russia’s Gamaleya Research Institute of Epidemiology and ...

The most widely ascribed explanation for the phenomenon ... ovarian cancer can increase the migration activity of human melanoma cells, with subsequent inhibition after incubation of the malignant ...

And today, New Year’s Day 2025, even Artificial Intelligence is singing the praises of Ivermectin and Fenbendazole as evidence-supported treatment for metastatic cancer ... breast, brain, melanoma and ...

As part of The Wistar Institute's Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...

The clinical approach, epidemiology, diagnostic procedures, and management, along with followup of superficial spreading malignant melanoma are discussed. A 45-year-old Caucasian female presented ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .